MedPath

Cheplapharm Arzneimittel Gmbh

Cheplapharm Arzneimittel Gmbh logo
🇳🇴Norway
Ownership
Subsidiary
Established
1998-01-01
Employees
321
Market Cap
-
Website
http://www.cheplapharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

245

CIMA_AEMPS:104
CANADA:47
SFDA:23
+3 more agencies

Drug Approvals

Valganciclovir Hydrochloride Tablets

Product Name
万赛维
Approval Number
国药准字HJ20150330
Approval Date
Sep 3, 2024
NMPA

Midazolam Maleate Tablets

Product Name
多美康
Approval Number
国药准字HJ20140591
Approval Date
Jun 17, 2024
NMPA

Ganciclovir for Injection

Product Name
赛美维
Approval Number
国药准字HJ20130374
Approval Date
Oct 10, 2023
NMPA

Alfacalcidol Soft Capsules

Product Name
依安凡
Approval Number
国药准字HJ20130514
Approval Date
Jul 13, 2023
NMPA

Alfacalcidol Soft Capsules

Product Name
依安凡
Approval Number
国药准字HJ20130513
Approval Date
Jul 13, 2023
NMPA

Alfacalcidol Drops

Product Name
依安凡
Approval Number
国药准字HJ20130464
Approval Date
Jul 11, 2023
NMPA

Orlistat Capsules

Product Name
赛尼可
Approval Number
国药准字HJ20171188
Approval Date
Jun 13, 2022
NMPA

Orlistat Capsules

Product Name
赛尼可
Approval Number
国药准字HJ20171189
Approval Date
Jun 13, 2022
NMPA

Paclitaxel Injection

Product Name
泰素
Approval Number
国药准字HJ20171227
Approval Date
Jan 8, 2021
NMPA

Ganciclovir for Injection

Product Name
赛美维
Approval Number
H20130374
Approval Date
Feb 17, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.